文献速递慢性肾脏病肾小球疾病

糖尿病肾病与慢性肾脏病的精准医学

Precision medicine in diabetic nephropathy and chronic kidney disease.
PubMed 文献 · Nephrol Dial Transplant · 2021-01-01

本文讨论2型糖尿病合并慢性肾脏病(CKD)的精准医学管理。CKD进展轨迹包括线性与非线性肾小球滤过率(GFR)下降,也可多年稳定;约五分之一患者在高白蛋白尿缺失时仍出现显著GFR下降(非蛋白尿性CKD),使白蛋白尿预测进展的适用性受限。

要点

  • CKD进展轨迹异质,包括线性与非线性GFR下降,老年患者可长期稳定。
  • 约五分之一患者无高白蛋白尿但GFR显著下降,白蛋白尿预测进展受限。
  • 识别早期CKD及持续进展患者对精准管理尤为重要。

核心结论

  • CKD在2型糖尿病患者中进展轨迹异质,白蛋白尿对非蛋白尿性CKD进展预测适用性有限。

研究设计与样本

  • 综述性文章,讨论2型糖尿病合并CKD的精准医学,未报告系统检索范围。

主要发现

  • CKD进展轨迹包括线性与非线性GFR下降,肾功能也可多年稳定,尤其老年人。
  • 约五分之一个体在高白蛋白尿缺失时仍出现显著GFR下降(非蛋白尿性CKD)。

临床怎么用

  • 识别早期CKD及持续进展患者,关注非蛋白尿性CKD的GFR下降。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Progressive chronic kidney disease (CKD) in individuals with type 2 diabetes mellitus is a global public health problem accompanied by substantial comorbidities and reduced life expectancy. In this respect, CKD leading to uremia can be seen as a systemic disease with a critical impact on virtually all organ systems. Thus it is of particular importance to identify patients with incipient CKD and ongoing CKD progression, but the individual course of CKD is challenging to predict. Patterns of progression in persons with CKD include linear and nonlinear trajectories of glomerular filtration rate (GFR) loss. Kidney function can also remain stable for years, especially in the elderly. In particular, one-fifth of individuals show a substantial GFR decline in the absence of high albuminuria (nonproteinuric CKD), rendering albuminuria less suitable for predicting the progression in such individuals.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Fliser D, Wanner C. Precision medicine in diabetic nephropathy and chronic kidney disease. Nephrol Dial Transplant. 2021. PMID: 34153982. doi:10.1093/ndt/gfaa380

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。